SCHEMBL6098103

SCHEMBL6098103

CCOc1ccc(-c2ccc(Cl)cc2)cc1C=O

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 6/20 0.55
TACR2 P21452 1/20 0.51
ALDH1A1 P00352 5/20 0.50
MAPT P10636 4/20 0.50
HPGD P15428 3/20 0.50
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
L3MBTL1 Q9Y468 3/20 0.50
KDM4E B2RXH2 3/20 0.50
TSHR P16473 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
LMNA P02545 3/20 0.45
ATM Q13315 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
POLB P06746 1/20 0.41
MAPK1 P28482 1/20 0.41
HSD17B10 Q99714 1/20 0.41
PKM P14618 1/20 0.41
AGPAT2 O15120 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6097520 0.89 ERN1 (0.50) ERN1TACR2ALDH1A1MAPTHPGD
SCHEMBL30902394 0.87 HPGD (0.64) ERN1TACR2ALDH1A1MAPTHPGD
SCHEMBL1185190 0.87 HPGD (0.64) ERN1TACR2ALDH1A1MAPTHPGD
SCHEMBL18003639 0.84 ALDH1A1 (0.67) ERN1ALDH1A1MAPTHPGDMEN1
SCHEMBL12678383 0.81 ALDH1A1 (0.47) ERN1ALDH1A1MAPTHPGDMEN1
SCHEMBL4731733 0.81 MAPT (0.47) ERN1ALDH1A1MAPTHPGDMEN1
SCHEMBL28772019 0.79 MEN1 (0.54) ERN1TACR2ALDH1A1MAPTHPGD
SCHEMBL6097515 0.78 ERN1 (0.51) ERN1ALDH1A1MAPTMEN1KMT2A
SCHEMBL3329518 0.77 HPGD (0.51) ERN1TACR2ALDH1A1MAPTHPGD
SCHEMBL28771916 0.77 PTPN1 (0.51) ERN1TACR2ALDH1A1MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7067535-B2 5-Phenylbenzylamine compounds, process for their production and intermediates for their synthesis TANABE SEIYAKU CO., LTD. (JP) 2006-06-27 US disclosed
US-20040097548-A1 5-Phenylbenzylamine compounds, process for their production and intermediates for their synthesis TANABE SEIYAKI CO., LTD. (JP) 2004-05-20 US disclosed
EP-1323713-A1 5-PHENYLBENZYLAMINE COMPOUNDS, PROCESS FOR THEIR PRODUCTION AND INTERMEDIATES FOR THEIR SYNTHESIS TANABE SEIYAKU CO., LTD. (JP) 2003-07-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040097548-A1 5-Phenylbenzylamine compounds, process for their production and intermediates for their synthesis CYP1B1, MAOB, HTR1B ERN1 1413/4885TACR2 1369/4885ALDH1A1 136/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.